LONDON--(BUSINESS WIRE)--Technavio’s latest global transplant diagnostic market report highlights three key emerging trends predicted to impact market growth through 2020. Technavio defines an emerging trend as something that has potential for significant impact on the market and contributes to its growth or decline.
“In countries such as the US, government initiatives and awareness programs about organ transplant are anticipated to significantly improve revenues for market vendors. In addition, healthcare reforms in the region will encourage medical facilities to adopt the latest, advanced diagnostics techniques for management of transplantation. Medical facilities are increasingly engaging in laboratory automation, which is leading to a shift towards molecular assays such as PCR and NGS techniques,” said Barath Palada, one of Technavio’s lead industry analysts for life sciences.
Technavio’s market research study identifies the following three emerging trends expected to propel the global transplant diagnostic market:
- Advances in technology
- Government initiatives
- Product approvals and launches
Advances in technology
Medical laboratories conventionally perform transplant diagnostics to analyze HLA. However, HLA analysis must be done in high-throughput laboratories with a limited number of staff. Molecular assay technologies, such as sequencing techniques and PCR-based assays help serve this purpose. Advanced NGS technologies help decipher the genetic information on a large scale and at an affordable price. For instance, Illumina's MiSeq system uses next-generation technology and offers high-resolution HLA typing for use by any clinical laboratory. In December 2015, Immucor and Sirona Genomics launched MIA FORA NGS, a high-resolution HLA typing solution that provides accurate, comprehensive coverage of 11 HLA genes. Similar advanced PCR technologies such as PCR-SSP, PCR-RFLP, PCR-SSCP, PCR-SSO, and PCR-SNP have made HLA analysis at the DNA level possible. Further advances in the field of molecular diagnostics will lead to the development and availability of innovative transplant diagnostics during the forecast period.
Initiatives and funding by governments of various countries help in the R&D of transplant diagnostics. These organizations include WHO and the World Health Assembly that implemented the WHA57.18 program to increase transplantation activities worldwide. In 2015, the Health Resources and Services Administration in the US initiated the Organ Donation and Transplantation Funding program and allocated USD 24 million for research. Similarly, the government in the UK allocated a budget of USD 28 billion in FY2015, of which USD 1.85 million was invested in medical research of HLA diagnosis conducted by universities and institutes. In 2014, the government in Australia funded doctors and nurses in 72 hospitals to work specifically on organ transplantation. Funding from government help hospitals, transplant centers, and research centers perform more transplantation diagnostics activities and this trend will augment the growth of this market over the next four years.
Product approvals and launches
The demand and use of transplant diagnostics have led to a rapid increase in new products launches. Many of these new products have received regulatory approvals, particularly FDA approvals in 2015, thereby increasing their accessibility among individuals and medical personnel. In 2015, Thermo Fisher Scientific introduced the NXType NGS HLA typing assay that includes molecular typing products such as SSO, SSP, and SBT technologies. Similarly, in 2015, Qiagen launched the GeneReader NGS system that provides NGS solution for laboratories and helps obtain accurate results. CareDx launched AlloMap that reduces the cost of post-transplant process. The product costs about USD 3,600 and can reduce the number of invasive biopsies and dosage of anti-rejection drugs. These developments will likely help sustain the growth of the market over the next four years.
Browse related reports:
- Global Liver Diseases Therapeutics Market 2015-2019
- Global Hepatitis Drugs Market 2015-2019
- Cystic Fibrosis Market in Europe 2015-2019
Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact email@example.com with your requirements and a link to our subscription platform.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.